SCHEMBL9309635

SCHEMBL9309635

Cc1ccc2oc(-c3ccccc3C#N)c(Br)c2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK2A2 P19784 2/20 0.40
CSNK2B P67870 2/20 0.40
CSNK2A1 P68400 1/20 0.40
KDM4E B2RXH2 6/20 0.39
MAPT P10636 3/20 0.39
MAOB P27338 2/20 0.39
MAOA P21397 1/20 0.39
KCNH2 Q12809 1/20 0.39
ALDH1A1 P00352 4/20 0.38
HPGD P15428 3/20 0.38
MEN1 O00255 1/20 0.38
NPC1 O15118 1/20 0.38
HTT P42858 1/20 0.38
RAB9A P51151 1/20 0.38
KMT2A Q03164 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
POLB P06746 1/20 0.36
TP53 P04637 2/20 0.36
CYP3A4 P08684 2/20 0.36
HSD17B10 Q99714 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9308247 0.86 KCNH2 (0.46) CSNK2A2CSNK2BCSNK2A1KDM4EMAPT
SCHEMBL9309638 0.82 PTGES (0.36) CSNK2A2CSNK2BCSNK2A1KDM4EMAPT
SCHEMBL9309957 0.82 MAPT (0.41) CSNK2A2CSNK2BCSNK2A1KDM4EMAPT
SCHEMBL9308810 0.82 KDM4E (0.38) CSNK2A2CSNK2BCSNK2A1KDM4EMAPT
SCHEMBL7441078 0.82 KDM4E (0.34) KDM4EALDH1A1KMT2A
SCHEMBL7442248 0.81 HTR7 (0.36) KDM4EALDH1A1HPGDTP53CYP3A4
SCHEMBL7439131 0.81 CYP1A2 (0.35) KDM4EALDH1A1HTTRAB9AKMT2A
SCHEMBL9312055 0.81 AR (0.38) CSNK2A2CSNK2BKDM4EMAPTKCNH2
SCHEMBL27370071 0.80 CYP1A2 (0.34) KDM4EALDH1A1CYP1A2
SCHEMBL9308252 0.79 TSHR (0.37) KDM4EMAPTMAOBKCNH2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5374646-A Treatment or prophylasix of hypertension and diseases associated with cognitive disorders GLAXO GROUP LIMITED (GB) 1994-12-20 US disclosed
EP-0559724-A1 BENZOFURAN AND BENZTHIOPHENE DERIVATIVES GLAXO GROUP LIMITED (GB) 1993-09-15 EP disclosed
WO-1992009600-A1 BENZOFURAN AND BENZTHIOPHENE DERIVATIVES GLAXO GROUP LIMITED (GB) 1992-06-11 WO disclosed
CN-1052672-A Benzofuran derivative GLAXO GROUP LTD (GB) 1991-07-03 CN disclosed
EP-0434249-A2 Benzofuran derivatives GLAXO GROUP LIMITED (GB) 1991-06-26 EP disclosed